Dose & Diagnose Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Dose & Diagnose General Information
Description
Operator of a digital platform intended to improve diagnosis accuracy by combining both doctors' and pharmacists' expertise. The company's AI-driven patient data analysis optimizes dosages and reduces medication, enabling clients to overuse telehealth consultations.
Contact Information
Corporate Office
- Sofia
- Bulgaria
Corporate Office
- Sofia
- Bulgaria
Dose & Diagnose Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 11-Dec-2024 | Completed | Generating Revenue |
Dose & Diagnose Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DEA Accelerate | Accelerator/Incubator |
Dose & Diagnose FAQs
-
Where is Dose & Diagnose headquartered?
Dose & Diagnose is headquartered in Sofia, Bulgaria.
-
What industry is Dose & Diagnose in?
Dose & Diagnose’s primary industry is Decision/Risk Analysis.
-
Is Dose & Diagnose a private or public company?
Dose & Diagnose is a Private company.
-
What is Dose & Diagnose’s current revenue?
The current revenue for Dose & Diagnose is .
-
Who are Dose & Diagnose’s investors?
DEA Accelerate has invested in Dose & Diagnose.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process